Outcome After Steroid Withdrawal in Heart Transplantation

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2253-2255

  Castel, M A ^a   Vallejos, I ^a   Ramos, P ^a   Arias, A ^a   Bravo, C ^a   Ferrero, M ^a   Rivero, D ^a   Sionis, A ^a   Perez Villa F ^a   Roig, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CHOLESTEROL; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONSENSUS; CORONARY ARTERY DISEASE; DRUG WITHDRAWAL; FEMALE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; KIDNEY FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METABOLISM; NEOPLASM; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; CHOLESTEROL; CHOLESTEROL, LDL; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; KIDNEY FUNCTION TESTS; PATIENT SELECTION; REOPERATION; RETROSPECTIVE STUDIES; SUBSTANCE WITHDRAWAL SYNDROME; SURVIVAL RATE; TIME FACTORS;

EID: 68949208500     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.028     Document Type: Article

References (13)

1. Baran D.A., Galin I.D., Gass A.L., et al. Current practices: immunosuppression induction, maintenance and rejection regimens in contemporary post-heart transplant patient treatment. Curr Opin Cardiol 17 (2002) 165
2. Crespo-Leiro M.G., Almenar L., Alonso-Pulpón L., et al. Conferencia de Consenso de los Grupos Españoles de Trasplante Cardiaco. Rev Esp Cardiol 7 Suppl (2007) 4B
3. Kobashigawa J.A., Stevenson L.W., Brownfield E.D., et al. Corticosteroid weaning late after heart transplantation relation to HLA-DR mismatching and long-term metabolic benefits. J Heart Lung Transplant 14 (1995) 963
4. Felkel T.O., Smith A.L., Reichenspurner H.C., et al. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal front steroid therapy. J Heart Lung Transplant 21 (2002) 530
5. Lake K.D., Reutzel T.J., Pritzker M.R., et al. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients. J Heart Lung Transplant 12 (1993) 580
6. Sánchez V., Delgado J., Gómez M.A., et al. Steroid withdrawal in non-immnunologically selected heart transplant recipients. Transplant Proc 34 (2002) 164
7. Mehra M.R., Uber P.A., Park M.H., et al. corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. Transplant Proc 36 (2004) 3152
8. Crespo-Leiro M.G., Paniagua M.J., Franco R., et al. Late steroid withdrawal after heart transplantation and incidence of acute rejection. Transplant Proc 39 (2007) 2372
9. Aurora P., Boucek M., Christie J., et al. Registry of the International Society for Heart and Lung Transplantation: Tenth Official Pediatric Lung and Heart/Lung Transplantation Report-2007. J Heart Lung Transplant 26 (2007) 1223
10. Billingham M.E. Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transpl 1 (1981) 25
11. Taylor D.O., Bristow M.R., O'Connell J.B., et al. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy. J Heart Lung Transplant 15 (1996) 1039
12. Olivari M.T., Jessen M.E., Baldwin B.J., et al. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. J Heart Lung Transplant 14 (1995) 127
13. Keogh A., Macdonald P., Harvison A., et al. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question. J Heart Lung Transplant 11 (1992) 421